American Conference Institute’s 4th Annual conference on:
The Definitive Forum on the Legal, Regulatory, and Commercial Realities of Biosimilars
Thursday, June 06 to Friday, June 07, 2013
New York Marriott Downtown, New York, NY
Attend the one event where the industry leaders driving the business of biosimilars unite to set the standards which will shape an evolving legal and regulatory landscape
With the election over and PPACA firmly established as law, the rush to the biosimilar market has begun in earnest. At ACI’s fourth annual Biosimilars conference, the key figures who are shaping the evolving biosimilar landscape--- leading policy makers, in-house representatives from branded and generic biotechnology and pharmaceutical companies, and top-tier litigators and patent prosecutors--- will convene to formulate solutions to the challenging questions left standing in the wake of the historic legislation:
The major players are preparing for the inevitable--- the litigation and the attacks on biosimilar IP that are sure to come
With a now estimated $140 billion in potential biologics sales at stake annually and a wave of patent expirations starting in 2014, there will be a hard-fought battle to protect and increase market share. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.
Hear What Prior Attendees are Saying about this Annual Leading Event:
- “One of the best CLEs I’ve been to in 10 years”
- “Excellent program – informative and thought-provoking.”
- “I thought all the speakers did an excellent job in terms of content and delivery.”
- “Excellent seminar. A lot of learning, new points of view talked about and dealt with.”
Full conference details are on the way shortly. If you are interested in speaking at this event, contact Nicole Cutrufello-Turner at email@example.com. For information on sponsoring or exhibiting at this event, contact Esther Fleischhacker at firstname.lastname@example.org.
Based on past success, spaces will fill up quickly. Register now by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering online at www.americanconference.com/biosimilars.
- click image for pdf -
- Actions -
- Share -
Thu, Jun 06, 2013
Fri, Jun 07, 2013
New York Marriott Downtown
New York, NY
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements.This course is identified as nontransitional for the purposes of CLE accreditation.
ACI certifies that the activity has been approved for CLE credit by the New York State Continuing Legal Education Board in the amount of 16.0 hours, of which 1.0 will apply to ethics. An additional 3.5 credit hours will apply to participation in either workshop.
ACI certifies that this activity has been approved for CLE credit by the State Bar of California in the amount of 13.5 hours, of which 1.0 will apply to ethics. An additional 3.0 credit hours will apply to participation in either workshop. You are required to bring your state bar number to complete the appropriate state forms during the conference. CLE credits are processed in 4-8 weeks after a conference is held.
ACI has a dedicated team which processes requests for state approval. Please note that event accreditation varies by state and ACI will make every effort to process your request.Questions about CLE credits for your state? Visit our online CLE Help Center at www.americanconference.com/CLE.